Similar articles for PMID: 15657157

Year	Number of Results
1980	1
1981	1
1982	1
1983	1
1984	7
1985	4
1986	4
1987	9
1988	5
1989	5
1990	5
1991	7
1992	6
1993	8
1994	13
1995	10
1996	15
1997	12
1998	13
1999	10
2000	26
2001	13
2002	13
2003	6
2004	11
2005	8
2006	3
2007	4
2008	9
2009	5
2010	4
2011	8
2012	3
2013	6
2014	8
2015	1
2016	5
2017	1
2019	5
2020	1
2021	3
2022	2
2023	1
2024	0

1

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.

Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto AM Jr. Whitney EJ, et al. Ann Intern Med. 2005 Jan 18;142(2):95-104. doi: 10.7326/0003-4819-142-2-200501180-00008. Ann Intern Med. 2005. PMID: 15657157 Clinical Trial.

2

Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.

[No authors listed] [No authors listed] Ann Intern Med. 2005 Jan 18;142(2):I46. doi: 10.7326/0003-4819-142-2-200501180-00003. Ann Intern Med. 2005. PMID: 15657152 No abstract available.

3

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.

Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM. Pasternak RC, et al. Ann Intern Med. 1996 Oct 1;125(7):529-40. doi: 10.7326/0003-4819-125-7-199610010-00001. Ann Intern Med. 1996. PMID: 8815751 Clinical Trial.

4

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Rubins HB, et al. N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604. N Engl J Med. 1999. PMID: 10438259 Free article. Clinical Trial.

5

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial. Robins SJ, et al. JAMA. 2001 Mar 28;285(12):1585-91. doi: 10.1001/jama.285.12.1585. JAMA. 2001. PMID: 11268266 Clinical Trial.

6

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.

Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD. Guyton JR, et al. Arch Intern Med. 2000 Apr 24;160(8):1177-84. doi: 10.1001/archinte.160.8.1177. Arch Intern Med. 2000. PMID: 10789612 Clinical Trial.

7

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Downs JR, et al. JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615. JAMA. 1998. PMID: 9613910 Clinical Trial.

8

Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.

Andrews TC, Whitney EJ, Green G, Kalenian R, Personius BE. Andrews TC, et al. Am J Cardiol. 1997 Oct 1;80(7):831-5. doi: 10.1016/s0002-9149(97)00531-6. Am J Cardiol. 1997. PMID: 9381993 Clinical Trial.

9

The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study.

Krasuski RA, Devendra GP, Cater G, Whitney EJ. Krasuski RA, et al. Am J Med Sci. 2011 May;341(5):378-82. doi: 10.1097/MAJ.0b013e318209d851. Am J Med Sci. 2011. PMID: 21358314 Clinical Trial.

10

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

AIM-HIGH Investigators; Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. AIM-HIGH Investigators, et al. N Engl J Med. 2011 Dec 15;365(24):2255-67. doi: 10.1056/NEJMoa1107579. Epub 2011 Nov 15. N Engl J Med. 2011. PMID: 22085343 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

277 results

Results by year